Literature DB >> 739174

Menopausal changes in bone remodeling.

R P Heaney, R R Recker, P D Saville.   

Abstract

Bone remodeling was measured by a calcium-kinetic method in 151 normal perimenopausal women, and the effect of estrogen status on remodeling level and skeletal balance was determined. Premenopausal women exhibited remodeling rates of 0.337 gm/day Ca for mineral accretion and 0.358 gm/day Ca for mineral resorption. The difference between the two rates (computed skeletal balance) was -0.021 gm/day Ca. Postmenopausal women treated with estrogen in a mean dose of 0.0188 mg equivalents of ethinyl estradiol exhibited values for accretion and resorption (0.332 and 0.351 gm/day Ca), essentially identical with those of the premenopausal group. However, untreated postmenopausal women exhibited remodeling rates of 0.387 gm/day Ca for accretion and 0.425 gm/day Ca for resorption, with a computed skeletal balance of -0.038 gm/day Ca. These values were significantly higher than those of either the premenopausal or treated postmenopausal groups. Paired studies across menopause in 15 of the women demonstrated a rise in remodeling rates virtually identical to that estimated from the differences between groups. Estrogen loss at menopause is thus associated with an apparent partial release from an inhibition of skeletal resorption, and this release is, in whole or part, responsible for the negative skeletal balance shift associated with the postmenopausal years.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 739174

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  78 in total

1.  Quantum concept of bone remodeling and turnover: implications for the pathogenesis of osteoporosis.

Authors:  A M Parfitt
Journal:  Calcif Tissue Int       Date:  1979-08-24       Impact factor: 4.333

Review 2.  Remodeling and skeletal fragility.

Authors: 
Journal:  Osteoporos Int       Date:  2003-08-29       Impact factor: 4.507

Review 3.  Molecular mechanisms for regulation of intestinal calcium absorption by vitamin D and other factors.

Authors:  James C Fleet; Ryan D Schoch
Journal:  Crit Rev Clin Lab Sci       Date:  2010-08       Impact factor: 6.250

4.  Timing of follow-up densitometry in hormone replacement therapy users for optimal osteoporosis prevention.

Authors:  Miguel A Checa; L Del Rio; J Rosales; X Nogués; J Vila; R Carreras
Journal:  Osteoporos Int       Date:  2004-12-23       Impact factor: 4.507

5.  Is there a causal role for IL-1 in postmenopausal bone loss?

Authors:  R Pacifici
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

6.  Serum bone Gla protein in streak gonad syndrome.

Authors:  J Zséli; P Bösze; P Lakatos; P Vargha; G Tarján; E Kollin; C Horváth; J László; I Holló
Journal:  Calcif Tissue Int       Date:  1991-06       Impact factor: 4.333

7.  Effects of ovariectomy on iliac trabecular bone in baboons (Papio anubis).

Authors:  C P Jerome; D B Kimmel; J A McAlister; D S Weaver
Journal:  Calcif Tissue Int       Date:  1986-09       Impact factor: 4.333

8.  Age-related changes in resorption cavity characteristics in human trabecular bone.

Authors:  P I Croucher; N J Garrahan; R W Mellish; J E Compston
Journal:  Osteoporos Int       Date:  1991-09       Impact factor: 4.507

9.  Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.

Authors:  R Civitelli; S Gonnelli; F Zacchei; S Bigazzi; A Vattimo; L V Avioli; C Gennari
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

10.  In vivo modulation of murine serum tumour necrosis factor and interleukin-6 levels during endotoxemia by oestrogen agonists and antagonists.

Authors:  S H Zuckerman; N Bryan-Poole; G F Evans; L Short; A L Glasebrook
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.